Improved in vivo targeting of BCL-2 phenotypic conversion through hollow gold nanoshell delivery.

Improved in vivo targeting of BCL-2 phenotypic conversion through hollow gold nanoshell delivery.
复制标题

DOI:
10.1007/s10495-019-01531-1
复制
发表时间:
2019-06
期刊:
Apoptosis : an international journal on programmed cell death
影响因子:
--
通讯作者:
Reich NO
Reich NO
中科院分区:
其他
文献类型:
--
作者:
Morgan E;Gamble JT;Pearce MC;Elson DJ;Tanguay RL;Kolluri SK;Reich NO

文献摘要

参考文献

相似文献

尽管新的癌症治疗方法被快速发现,但缺乏有效的递送手段和癌症耐药性阻碍了许多有前途的治疗方法。我们展示了一种方法,面对这两个问题的Bcl-2功能转换肽,NuBCP-9,使用中空的金纳米壳的光激活交付。这种方法不仅显示出在体外将肽的功效增加30倍,而且还显示出将紫杉醇抗性H460肺异种移植肿瘤生长减少56.4%。
Although new cancer therapeutics are discovered at a rapid pace, lack of effective means of delivery and cancer chemoresistance thwart many of the promising therapeutics. We demonstrate a method that confronts both of these issues with the light-activated delivery of a Bcl-2 functional converting peptide, NuBCP-9, using hollow gold nanoshells. This approach has shown not only to increase the efficacy of the peptide 30-fold in vitro but also has shown to reduce paclitaxel resistant H460 lung xenograft tumor growth by 56.4%.
DOI: 10.18632/oncotarget.12132
发表时间: 2016-10-25
期刊: Oncotarget
影响因子: --
作者:
Bodo J;Zhao X;Durkin L;Souers AJ;Phillips DC;Smith MR;Hsi ED
通讯作者: Hsi ED
DOI: 10.1016/j.ccr.2008.09.002
发表时间: 2008-10-07
期刊: Cancer cell
影响因子: 50.3
作者:
Kolluri SK;Zhu X;Zhou X;Lin B;Chen Y;Sun K;Tian X;Town J;Cao X;Lin F;Zhai D;Kitada S;Luciano F;O'Donnell E;Cao Y;He F;Lin J;Reed JC;Satterthwait AC;Zhang XK
通讯作者: Zhang XK
DOI: 10.1038/sj.onc.1206004
发表时间: 2002-10-31
期刊: ONCOGENE
影响因子: 8
作者:
Real, PJ;Sierra, A;Fernandez-Luna, JL
通讯作者: Fernandez-Luna, JL
DOI: 10.1002/aja.1002030302
发表时间: 1995-07-01
影响因子: 2.5
作者:
KIMMEL, CB;BALLARD, WW;SCHILLING, TF
通讯作者: SCHILLING, TF
DOI: 10.1021/jacs.5b06710
发表时间: 2015-08-19
影响因子: 15
作者:
Liu, Hong-Yi;Wu, Pei-Jing;Chant, Yang-Hsiang
通讯作者: Chant, Yang-Hsiang